Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 22 |
NetGPI | no | yes: 0, no: 22 |
Term | Name | Level | Count |
---|---|---|---|
GO:0016020 | membrane | 2 | 23 |
GO:0110165 | cellular anatomical entity | 1 | 23 |
Related structures:
AlphaFold database: A4HRX8
Term | Name | Level | Count |
---|---|---|---|
GO:0006810 | transport | 3 | 23 |
GO:0008104 | protein localization | 4 | 23 |
GO:0009987 | cellular process | 1 | 23 |
GO:0015031 | protein transport | 4 | 23 |
GO:0016192 | vesicle-mediated transport | 4 | 23 |
GO:0033036 | macromolecule localization | 2 | 23 |
GO:0045184 | establishment of protein localization | 3 | 23 |
GO:0051179 | localization | 1 | 23 |
GO:0051234 | establishment of localization | 2 | 23 |
GO:0051641 | cellular localization | 2 | 23 |
GO:0070727 | cellular macromolecule localization | 3 | 23 |
GO:0071702 | organic substance transport | 4 | 23 |
GO:0071705 | nitrogen compound transport | 4 | 23 |
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_C14_Caspase3-7 | 2 | 6 | PF00656 | 0.609 |
CLV_PCSK_SKI1_1 | 127 | 131 | PF00082 | 0.270 |
CLV_PCSK_SKI1_1 | 188 | 192 | PF00082 | 0.480 |
DOC_CYCLIN_RxL_1 | 30 | 41 | PF00134 | 0.536 |
DOC_MAPK_MEF2A_6 | 184 | 191 | PF00069 | 0.671 |
DOC_USP7_MATH_1 | 200 | 204 | PF00917 | 0.375 |
DOC_WW_Pin1_4 | 196 | 201 | PF00397 | 0.314 |
LIG_14-3-3_CanoR_1 | 184 | 188 | PF00244 | 0.639 |
LIG_Actin_WH2_2 | 173 | 190 | PF00022 | 0.477 |
LIG_BRCT_BRCA1_1 | 114 | 118 | PF00533 | 0.275 |
LIG_BRCT_BRCA1_1 | 194 | 198 | PF00533 | 0.381 |
LIG_eIF4E_1 | 32 | 38 | PF01652 | 0.530 |
LIG_FHA_1 | 114 | 120 | PF00498 | 0.341 |
LIG_FHA_1 | 184 | 190 | PF00498 | 0.558 |
LIG_FHA_1 | 44 | 50 | PF00498 | 0.748 |
LIG_FHA_1 | 69 | 75 | PF00498 | 0.596 |
LIG_FHA_2 | 126 | 132 | PF00498 | 0.584 |
LIG_GBD_Chelix_1 | 145 | 153 | PF00786 | 0.230 |
LIG_GBD_Chelix_1 | 169 | 177 | PF00786 | 0.257 |
LIG_LIR_Gen_1 | 192 | 201 | PF02991 | 0.506 |
LIG_LIR_Gen_1 | 75 | 86 | PF02991 | 0.334 |
LIG_LIR_Nem_3 | 178 | 182 | PF02991 | 0.343 |
LIG_LIR_Nem_3 | 195 | 201 | PF02991 | 0.357 |
LIG_NRBOX | 85 | 91 | PF00104 | 0.257 |
LIG_PCNA_PIPBox_1 | 147 | 156 | PF02747 | 0.246 |
LIG_SH2_CRK | 32 | 36 | PF00017 | 0.589 |
LIG_SH2_SRC | 141 | 144 | PF00017 | 0.257 |
LIG_SH2_STAP1 | 175 | 179 | PF00017 | 0.283 |
LIG_SH2_STAP1 | 193 | 197 | PF00017 | 0.459 |
LIG_SH2_STAP1 | 70 | 74 | PF00017 | 0.575 |
LIG_SH2_STAT3 | 182 | 185 | PF00017 | 0.644 |
LIG_SH2_STAT3 | 26 | 29 | PF00017 | 0.626 |
LIG_SH2_STAT5 | 141 | 144 | PF00017 | 0.374 |
LIG_SH2_STAT5 | 179 | 182 | PF00017 | 0.337 |
LIG_SH2_STAT5 | 70 | 73 | PF00017 | 0.631 |
LIG_Sin3_3 | 163 | 170 | PF02671 | 0.207 |
LIG_SxIP_EBH_1 | 173 | 184 | PF03271 | 0.362 |
LIG_UBA3_1 | 149 | 158 | PF00899 | 0.381 |
MOD_CK1_1 | 192 | 198 | PF00069 | 0.432 |
MOD_CK1_1 | 36 | 42 | PF00069 | 0.659 |
MOD_CK1_1 | 63 | 69 | PF00069 | 0.615 |
MOD_CK2_1 | 125 | 131 | PF00069 | 0.430 |
MOD_GlcNHglycan | 150 | 153 | PF01048 | 0.372 |
MOD_GlcNHglycan | 202 | 205 | PF01048 | 0.196 |
MOD_GlcNHglycan | 5 | 8 | PF01048 | 0.514 |
MOD_GSK3_1 | 141 | 148 | PF00069 | 0.335 |
MOD_GSK3_1 | 192 | 199 | PF00069 | 0.477 |
MOD_GSK3_1 | 68 | 75 | PF00069 | 0.614 |
MOD_GSK3_1 | 99 | 106 | PF00069 | 0.258 |
MOD_N-GLC_2 | 210 | 212 | PF02516 | 0.207 |
MOD_NEK2_1 | 103 | 108 | PF00069 | 0.348 |
MOD_NEK2_1 | 113 | 118 | PF00069 | 0.366 |
MOD_NEK2_1 | 3 | 8 | PF00069 | 0.677 |
MOD_NEK2_1 | 68 | 73 | PF00069 | 0.578 |
MOD_NEK2_2 | 183 | 188 | PF00069 | 0.633 |
MOD_PIKK_1 | 25 | 31 | PF00454 | 0.639 |
MOD_PIKK_1 | 68 | 74 | PF00454 | 0.633 |
MOD_PKA_1 | 99 | 105 | PF00069 | 0.334 |
MOD_PKA_2 | 183 | 189 | PF00069 | 0.625 |
MOD_PKA_2 | 72 | 78 | PF00069 | 0.534 |
MOD_Plk_1 | 66 | 72 | PF00069 | 0.595 |
MOD_Plk_4 | 113 | 119 | PF00069 | 0.339 |
MOD_Plk_4 | 145 | 151 | PF00069 | 0.315 |
MOD_Plk_4 | 175 | 181 | PF00069 | 0.386 |
MOD_Plk_4 | 192 | 198 | PF00069 | 0.520 |
MOD_Plk_4 | 33 | 39 | PF00069 | 0.580 |
MOD_ProDKin_1 | 196 | 202 | PF00069 | 0.314 |
MOD_SUMO_rev_2 | 17 | 23 | PF00179 | 0.538 |
TRG_ENDOCYTIC_2 | 193 | 196 | PF00928 | 0.502 |
TRG_ENDOCYTIC_2 | 32 | 35 | PF00928 | 0.563 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N0P5I1 | Leptomonas seymouri | 69% | 99% |
A0A0N1I3M5 | Leptomonas seymouri | 31% | 100% |
A0A0S4JF33 | Bodo saltans | 33% | 100% |
A0A1X0P315 | Trypanosomatidae | 31% | 100% |
A0A1X0P7F6 | Trypanosomatidae | 30% | 100% |
A0A1X0P987 | Trypanosomatidae | 44% | 100% |
A0A3Q8IBK0 | Leishmania donovani | 39% | 100% |
A0A3S5H567 | Leishmania donovani | 100% | 100% |
A0A3S5H5K3 | Leishmania donovani | 39% | 100% |
A0A422N175 | Trypanosoma rangeli | 45% | 100% |
A4H3Q4 | Leishmania braziliensis | 86% | 100% |
A4HDV3 | Leishmania braziliensis | 40% | 100% |
A4HSK3 | Leishmania infantum | 39% | 100% |
A4I148 | Leishmania infantum | 39% | 100% |
C9ZKI8 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 42% | 78% |
E9ACN7 | Leishmania major | 95% | 100% |
E9AJX6 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 94% | 100% |
E9AKI7 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 38% | 100% |
E9AX82 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 38% | 100% |
Q4QA90 | Leishmania major | 40% | 100% |
Q4QJC1 | Leishmania major | 39% | 100% |